Jim Bres - Comments

Latest Comments
Conatus Pharmaceutical: Act II In Fighting Liver Disease
10 years ago

I agree that many catalysts are in the near term and $15 is very likely given any good phase-2 results.

imho

jb

In this article: JNJ, PFE, ACHN, GILD, CNAT
1 to 1 of 1 comments

Following (0)

Followers (0)

Stocks I follow

General Stats

Article Comments

Received: 0
Created: 0